Mebutamate

This image is provided by the National Library of Medicine.

WikiDoc Resources for Mebutamate
Articles
Most recent articles on Mebutamate Most cited articles on Mebutamate Review articles on Mebutamate Articles on Mebutamate in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Mebutamate Images of Mebutamate Photos of Mebutamate Podcasts & MP3s on Mebutamate Videos on Mebutamate
Evidence Based Medicine
Cochrane Collaboration on Mebutamate Bandolier on Mebutamate TRIP on Mebutamate
Clinical Trials
Ongoing Trials on Mebutamate at Clinical Trials.gov Trial results on Mebutamate Clinical Trials on Mebutamate at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Mebutamate NICE Guidance on Mebutamate NHS PRODIGY Guidance FDA on Mebutamate CDC on Mebutamate
Books
Books on Mebutamate
News
Mebutamate in the news Be alerted to news on Mebutamate News trends on Mebutamate
Commentary
Blogs on Mebutamate
Definitions
Definitions of Mebutamate
Patient Resources / Community
Patient resources on Mebutamate Discussion groups on Mebutamate Patient Handouts on Mebutamate Directions to Hospitals Treating Mebutamate Risk calculators and risk factors for Mebutamate
Healthcare Provider Resources
Symptoms of Mebutamate Causes & Risk Factors for Mebutamate Diagnostic studies for Mebutamate Treatment of Mebutamate
Continuing Medical Education (CME)
CME Programs on Mebutamate
International
Mebutamate en Espanol Mebutamate en Francais
Business
Mebutamate in the Marketplace Patents on Mebutamate
Experimental / Informatics
List of terms related to Mebutamate

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Mebutamate (Capla, Dormate) is an anxiolytic and sedative drug with antihypertensive effects of the carbamate class. It has effects comparable to those of barbiturates such as secobarbital, but is only around 1/3 the potency of secobarbital as a sedative. Side effects include dizziness and headaches. Mebutamate is one of many GABAergic drugs which act via allosteric agonism of the GABA_A receptor at the β-subreceptor similair to barbiturates. In contrast, benzodiazepines act at the α-subreceptor. As such, carbamates and barbiturates, possess analgesic properties which the benzodiazepine class of drugs do not. Other carbamates with the same mechanism of action and pharmacological properties include meprobamate, carisoprodol, felbamate, and tybamate).